Gyngell Christopher, Lynch Fiona, Vears Danya, Bowman-Smart Hilary, Savulescu Julian, Christodoulou John
Biomedical Ethics Research Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.
J Med Ethics. 2025 Feb 21;51(3):205-211. doi: 10.1136/jme-2022-108471.
Genomic sequencing (GS) is increasingly used in paediatric medicine to aid in screening, research and treatment. Some health systems are trialling GS as a first-line test in newborn screening programmes. Questions about what to do with genomic data after it has been generated are becoming more pertinent. While other research has outlined the ethical reasons for storing deidentified genomic data to be used in research, the ethical case for storing data for future clinical use has not been explicated. In this paper, we examine the ethical case for storing genomic data with the intention of using it as a lifetime health resource. In this model, genomic data would be stored with the intention of reanalysis at certain points through one's life. We argue this could benefit individuals and create an important public resource. However, several ethical challenges must first be met to achieve these benefits. We explore issues related to privacy, consent, justice and equality. We conclude by arguing that health systems should be moving towards futures that allow for the sequential interrogation of genomic data throughout the lifespan.
基因组测序(GS)在儿科学中越来越多地用于辅助筛查、研究和治疗。一些卫生系统正在试验将GS作为新生儿筛查项目的一线检测方法。关于生成基因组数据后如何处理这些数据的问题变得越来越重要。虽然其他研究已经概述了存储去识别化基因组数据用于研究的伦理原因,但存储数据以供未来临床使用的伦理依据尚未得到阐明。在本文中,我们探讨了将基因组数据存储起来并意图将其用作终身健康资源的伦理依据。在这种模式下,基因组数据将被存储起来,以便在人的一生中的某些时候进行重新分析。我们认为这可能会使个人受益,并创建一项重要的公共资源。然而,要实现这些益处,必须首先应对若干伦理挑战。我们探讨了与隐私、同意、公正和平等相关的问题。我们最后认为,卫生系统应朝着允许在整个生命周期中对基因组数据进行连续询问的未来发展。